S68 Cost Savings Validation of an Emergency Department Acute Pancreatitis Pathway

Introduction: Acute pancreatitis (AP) is a leading gastrointestinal cause of hospitalization, resulting in an estimated $2.5 billion in annual costs in the U.S. Beth Israel Deaconess Medical Center (BIDMC) implemented an emergency department (ED)-based protocol to streamline AP triage and management, classifying patients for either observation with possible ED discharge or inpatient admission, with significant implications for cost and patient disruption. Our project aimed to externally validate the BIDMC AP pathway by evaluating clinical outcomes and potential cost savings for patients who could be safely discharged. Methods: We used a prospectively collected database of patients with mild AP at LA General Hospital (LAG). The BIDMC safe discharge protocol was applied retrospectively to assess cohort comparability and identify patients who would have qualified for ED discharge. We then compared this theoretical cohort to actual patient triage and calculated differences in inpatient days and associated costs, using the average daily reimbursement rate at our center for AP. We extrapolated findings based on 288,820 annual U.S. admissions for pancreatitis and a published savings estimate of $1,720.50 per avoided admission. Results: We identified 704 patients with mild AP at LAG over a 5-year period. While LAG demographics differed from BIDMC, disease severity, etiology, and pathway eligibility were similar. Applying BIDMC criteria, 210 patients (29.8%) at LAG would have been eligible for ED discharge, comparable to the 26.0% at BIDMC (P = NS). In practice, only 40 patients (5.6%) were discharged, and 170 eligible patients were admitted, resulting in 3,572.5 inpatient days and an estimated $8.1 million in costs. Assuming national discharge patterns mirror those at LAG, implementing the Safe for ED Discharge pathway could yield $120 million in annual savings. Conclusion: We applied the BIDMC ED pancreatitis protocol to a large safety-net hospital population and found substantial potential cost savings.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001126732.15373.9f
Primary Topic
Healthcare cost, quality, practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S68 Cost Savings Validation of an Emergency Department Acute Pancreatitis Pathway

Alejandro Arias Vásquez, Kabir Rahal, Sunil Sheth, Daniel Wang et al.
The American Journal of Gastroenterology
Healthcare cost, quality, practices
article

S68 Cost Savings Validation of an Emergency Department Acute Pancreatitis Pathway

Alejandro Arias Vásquez, Kabir Rahal, Sunil Sheth, Daniel Wang, James Buxbaum, Helen Lee, Cameron M. Quon, Lucas Nastaskin
article en

Abstract

Introduction: Acute pancreatitis (AP) is a leading gastrointestinal cause of hospitalization, resulting in an estimated $2.5 billion in annual costs in the U.S. Beth Israel Deaconess Medical Center (BIDMC) implemented an emergency department (ED)-based protocol to streamline AP triage and management, classifying patients for either observation with possible ED discharge or inpatient admission, with significant implications for cost and patient disruption. Our project aimed to externally validate the BIDMC AP pathway by evaluating clinical outcomes and potential cost savings for patients who could be safely discharged. Methods: We used a prospectively collected database of patients with mild AP at LA General Hospital (LAG). The BIDMC safe discharge protocol was applied retrospectively to assess cohort comparability and identify patients who would have qualified for ED discharge. We then compared this theoretical cohort to actual patient triage and calculated differences in inpatient days and associated costs, using the average daily reimbursement rate at our center for AP. We extrapolated findings based on 288,820 annual U.S. admissions for pancreatitis and a published savings estimate of $1,720.50 per avoided admission. Results: We identified 704 patients with mild AP at LAG over a 5-year period. While LAG demographics differed from BIDMC, disease severity, etiology, and pathway eligibility were similar. Applying BIDMC criteria, 210 patients (29.8%) at LAG would have been eligible for ED discharge, comparable to the 26.0% at BIDMC (P = NS). In practice, only 40 patients (5.6%) were discharged, and 170 eligible patients were admitted, resulting in 3,572.5 inpatient days and an estimated $8.1 million in costs. Assuming national discharge patterns mirror those at LAG, implementing the Safe for ED Discharge pathway could yield $120 million in annual savings. Conclusion: We applied the BIDMC ED pancreatitis protocol to a large safety-net hospital population and found substantial potential cost savings.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 52%
Healthcare cost, quality, practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.